Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Wawrzynczak

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|October 1, 1991
Systemic immunotoxin therapy of cancer: advances and prospectsE J Wawrzynczak
Anti-Cancer Drug Design|October 1, 1992
Rational design of immunotoxins: current progress and future prospectsE J Wawrzynczak
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Preparation of cytotoxic antibody-toxin conjugatesA J Cumber, E J Wawrzynczak
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Immunoaffinity purification and quantification of antibody-toxin conjugatesE J Wawrzynczak, A J Cumber
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Preparation of cytotoxic antibody-toxin conjugatesA J Cumber, E J Wawrzynczak
The British Journal of Cancer. Supplement|June 1, 1991
Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicityE J Derbyshire, E J Wawrzynczak
International Journal of Cancer|October 21, 1992
An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancerE J Derbyshire, E J Wawrzynczak
Biochemistry International|August 1, 1984
Isolation and nucleotide sequence of a cDNA encoding human calmodulinE J Wawrzynczak, R N Perham
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Immunoaffinity purification and quantification of antibody-toxin conjugatesE J Wawrzynczak, A J Cumber
Immunology Today|October 1, 1992
Immunotoxins: the power and the gloryE J Wawrzynczak, E J Derbyshire
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|October 1, 1991
Systemic immunotoxin therapy of cancer: advances and prospectsE J Wawrzynczak
Anti-Cancer Drug Design|October 1, 1992
Rational design of immunotoxins: current progress and future prospectsE J Wawrzynczak
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Preparation of cytotoxic antibody-toxin conjugatesA J Cumber, E J Wawrzynczak
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Immunoaffinity purification and quantification of antibody-toxin conjugatesE J Wawrzynczak, A J Cumber
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Preparation of cytotoxic antibody-toxin conjugatesA J Cumber, E J Wawrzynczak
The British Journal of Cancer. Supplement|June 1, 1991
Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicityE J Derbyshire, E J Wawrzynczak
International Journal of Cancer|October 21, 1992
An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancerE J Derbyshire, E J Wawrzynczak
Biochemistry International|August 1, 1984
Isolation and nucleotide sequence of a cDNA encoding human calmodulinE J Wawrzynczak, R N Perham
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Immunoaffinity purification and quantification of antibody-toxin conjugatesE J Wawrzynczak, A J Cumber
Immunology Today|October 1, 1992
Immunotoxins: the power and the gloryE J Wawrzynczak, E J Derbyshire
Pageof 5